Metformin

Long COVIDLong COVID Prevention · Acute COVID

Pricing example

RTHM Safety Assessment Fee
Paid to RTHM. Every 90 days, only if approved.
$49
Pharmacy cost
14-day supply + shipping
Expect higher medication cost during titration period
$5
Estimated total for 14 days
With RTHM discount
$54

Minimize Acute COVID-19 Symptoms
Metformin offers antiviral properties that help reduce the severity of acute COVID-19 symptoms, lowering viral loads and minimizing complications.
Inflammation Reduction
Metformin exhibits anti-inflammatory effects, potentially mitigating systemic inflammation characteristic of acute COVID-19 and Long COVID.
Reduced Risk of Long COVID
Research shows that metformin reduces the risk of Long COVID by up to 53% when taken within the first week of infection.

Metformin has been shown to help with:

Patients experiencing acute COVID-19 or at risk of Long COVID may find metformin a safe and effective preventive treatment option.

Study #1: Minimize Acute COVID-19 Symptoms
Metformin demonstrated antiviral properties in a study where participants treated with metformin during acute COVID-19 experienced a fourfold reduction in viral load compared to the placebo group.
Metformin and Antiviral Effects in Acute COVID-19
View Study
Study #2: Inflammation Reduction
Metformin exhibits anti-inflammatory properties that may mitigate systemic inflammation present in acute COVID-19 and Long COVID. These effects could reduce the severity of acute infections and the risk of Long COVID development.
Metformin May Reduce Long COVID in Non-Diabetic Population
View Study
Study #3: Reduced Risk of Long COVID
Data presented at the 2024 Infectious Disease Week Annual Meeting revealed that metformin reduced the risk of Long COVID by 53% when prescribed within the first week of an acute SARS-CoV-2 infection.
Metformin for Long COVID Prevention and Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
View Study

Long COVIDLong COVID Prevention · Acute COVID

RTHM Safety Assessment Fee
Paid to RTHM. Every 90 days, only if approved.
$49
Pharmacy cost
14-day supply + shipping
Expect higher medication cost during titration period
$5
Estimated total for 14 days
With RTHM discount
$54

Minimize Acute COVID-19 Symptoms
Metformin offers antiviral properties that help reduce the severity of acute COVID-19 symptoms, lowering viral loads and minimizing complications.
Inflammation Reduction
Metformin exhibits anti-inflammatory effects, potentially mitigating systemic inflammation characteristic of acute COVID-19 and Long COVID.
Reduced Risk of Long COVID
Research shows that metformin reduces the risk of Long COVID by up to 53% when taken within the first week of infection.

Metformin has been shown to help with:

Patients experiencing acute COVID-19 or at risk of Long COVID may find metformin a safe and effective preventive treatment option.

Study #1: Minimize Acute COVID-19 Symptoms
Metformin demonstrated antiviral properties in a study where participants treated with metformin during acute COVID-19 experienced a fourfold reduction in viral load compared to the placebo group.
Metformin and Antiviral Effects in Acute COVID-19
View Study
Study #2: Inflammation Reduction
Metformin exhibits anti-inflammatory properties that may mitigate systemic inflammation present in acute COVID-19 and Long COVID. These effects could reduce the severity of acute infections and the risk of Long COVID development.
Metformin May Reduce Long COVID in Non-Diabetic Population
View Study
Study #3: Reduced Risk of Long COVID
Data presented at the 2024 Infectious Disease Week Annual Meeting revealed that metformin reduced the risk of Long COVID by 53% when prescribed within the first week of an acute SARS-CoV-2 infection.
Metformin for Long COVID Prevention and Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
View Study